Since Ang-based hCFPs rely on cytoplasmic deployment of apoptosis-inducing Ang, target tumor cells can protect themselves by expressing inhibitor proteins such as RNH1 and rapidly neutralizing wild-type (WT) Ang. This evidence concerns the gene RNH1 and neoplasm.